Retinoblastoma

Retinoblastoma is a malignant intraocular tumor that develops from immature retinal cells in young children (under 3 years of age).

Children with this disease are at risk of losing one or both eyes and complete vision loss if the tumor is not diagnosed and treated as soon as possible by doctors who specialize in this childhood tumor. 

Treatment of this extremely rare disease in children should be carried out in specialized clinics.

We conduct a preliminary analysis of each clinical case in order to develop the most effective strategy for providing medical care to each patient, including the use of high technologies.

Our cure rate for retinoblastoma is over 95%. 

Why the Center for Children’s Oncology, Hematology and Immunology?

It is important to establish the correct diagnosis.

In our institution, experienced specialists will carry out a complex diagnostic stage:

1. examination of the fundus under anesthesia in conditions of drug-induced mydriasis (dilated pupil) with a binocular ophthalmoscope and aspheric lenses;
2. photo registration of the fundus on a pediatric retinal camera;
3. ultrasound examination of the eyeballs and ultrasound biomicroscopy;
4. MRI of the orbits and brain with contrast enhancement.
5. molecular examination of peripheral blood to determine the congenital form of the disease (this is important in identifying familial forms of the disease).

It is important to prescribe the correct treatment

Our institution uses all possible modern methods for the treatment of retinoblastoma:

1. systemic chemotherapy;
2. superselective intra-arterial chemotherapy;
3. laser transpupillary thermotherapy;
4. intravitreal injections of cytostatic drugs and cryodestruction of tumors;
5. If the tumor spreads beyond the eye, hematopoietic stem cell transplantation and external beam radiation therapy are additionally used.